Immune Cell Subtyping in Indian Triple-Negative Breast Cancer Tumor Microenvironment with Variable Treatment Response

被引:0
|
作者
Vaid, P. [1 ]
Yadav, D. [2 ]
Kanase, P. [2 ]
Kadu, S. [2 ]
Kelkar, D. [2 ]
Shashidhara, L. [2 ,3 ]
Koppiker, C. [4 ]
Kulkarni, M. [2 ]
机构
[1] Ashoka Univ, Pune, Haryana, India
[2] Indian Inst Sci Educ & Res IISER Pune & Prashanti, Ctr Translat Canc Res, Pune, Maharashtra, India
[3] Natl Ctr Biol Sci, Bangalore, Karnataka, India
[4] Prashanti Canc Care Miss, Pune, Maharashtra, India
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
ST016
引用
收藏
页码:S94 / S94
页数:1
相关论文
共 50 条
  • [41] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    James Isaacs
    Carey Anders
    Heather McArthur
    Jeremy Force
    Current Treatment Options in Oncology, 2021, 22
  • [42] Circulating microRNAs and their role in the immune response in triple-negative breast cancer
    Pina-Sanchez, Patricia
    Valdez-Salazar, Hilda-Alicia
    Ruiz-Tachiquin, Martha-Eugenia
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [43] Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
    Yam, Clinton
    Yen, Er-Yen
    Chang, Jeffrey T.
    Bassett, Roland L., Jr.
    Alatrash, Gheath
    Garber, Haven
    Huo, Lei
    Yang, Fei
    Philips, Anne, V
    Ding, Qing-Qing
    Lim, Bora
    Ueno, Naoto T.
    Kannan, Kasthuri
    Sun, Xiangjie
    Sun, Baohua
    Cuentas, Edwin Roger Parra
    Symmans, William Fraser
    White, Jason B.
    Ravenberg, Elizabeth
    Seth, Sahil
    Guerriero, Jennifer L.
    Rauch, Gaiane M.
    Damodaran, Senthil
    Litton, Jennifer K.
    Wargo, Jennifer A.
    Hortobagyi, Gabriel N.
    Futreal, Andrew
    Wistuba, Ignacio I.
    Sun, Ryan
    Moulder, Stacy L.
    Mittendorf, Elizabeth A.
    CLINICAL CANCER RESEARCH, 2021, 27 (19) : 5365 - 5375
  • [44] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    Isaacs, James
    Anders, Carey
    McArthur, Heather
    Force, Jeremy
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (05)
  • [45] Triple-negative breast Cancer risk: Ancestry and immune response.
    Ford, Marvella E.
    Brown, Erika T.
    Turner, David P.
    Findlay, Victoria J.
    Esnaola, Nestor F.
    Alberg, Anthony J.
    Bolick, Susan
    Hurley, Deborah
    Kramer, Rita
    Salley, Judith D.
    Cunningham, Joan E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 66 - 66
  • [46] Understanding triple-negative breast cancer immune microenvironment by disease stages, obesity, and race
    Hossain, Fokhrul
    Danos, Denise
    Zabaleta, Jovanny
    Wu, Jiande
    Lynch, Mary Anne
    Del Valle, Luis
    Wu, Xiao-Cheng
    Ochoa, Augusto
    Hicks, Chindo
    Miele, Lucio
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women
    Tess O’Meara
    Anton Safonov
    David Casadevall
    Tao Qing
    Andrea Silber
    Brigid Killelea
    Christos Hatzis
    Lajos Pusztai
    Breast Cancer Research and Treatment, 2019, 175 : 247 - 259
  • [48] Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
    Bai, Xupeng
    Ni, Jie
    Beretov, Julia
    Graham, Peter
    Li, Yong
    JOURNAL OF THE NATIONAL CANCER CENTER, 2021, 1 (03): : 75 - 87
  • [49] Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women
    O'Meara, Tess
    Safonov, Anton
    Casadevall, David
    Qing, Tao
    Silber, Andrea
    Killelea, Brigid
    Hatzis, Christos
    Pusztai, Lajos
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 247 - 259
  • [50] Spatial mapping of the immune microenvironment in primary triple-negative breast cancer (TNBC) and association with neoadjuvant therapy response
    Telli, M. L.
    Vinayak, S.
    Khododoust, M. S.
    Gruber, J. J.
    Ford, J. M.
    Sanchez, P.
    Banayan, N.
    Azimi, S.
    Tumeh, P. C.
    Newman, A. M.
    Alizadeh, A. A.
    CANCER RESEARCH, 2019, 79 (04)